Additionally, TNF- has been shown to induce CCL2 production, and this mechanism is considered significant in metastatic liver diseases [197]
The LEADER Trial (Once-Daily Liraglutide) The LEADER trial primarily assessed the cardiovascular safety of once-daily liraglutide compared to placebo [26]
For patients with prominent neurological symptoms, the Neural Zoomer Plus can reveal whether mold-triggered immune activation has progressed to autoimmune responses against neural antigens
We address GLP-1 side effects the same week they come up, with dose adjustments, slower titration, supportive care, and close follow-up
A splice variant of PPARG is upregulated in the granulosa cells of PCOS patients and may lead to follicular arrest by altering protein function and the transcription of downstream genes involved in cell proliferation, apoptosis, and communication (52)